Biomarkers for preclinical Alzheimer's disease
著者
書誌事項
Biomarkers for preclinical Alzheimer's disease
(Neuromethods, 137)(Springer protocols)
Humana Press, c2018
- : pbk
大学図書館所蔵 全1件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
内容説明・目次
内容説明
This volume discusses the importance of imaging, fluid, and genetic biomarkers in detecting the earliest pre-symptomatic stages of Alzheimer's disease (AD). The chapters in this book are separated into five parts. Part one explores the reasons why we need improved approaches for early detection and diagnosis of AD. Part two describes clinical and research techniques for preclinical AD diagnosis. Part three looks at the current methods in use to diagnose AD and how they can also be used for early detection in healthy older individuals. Parts four and five talk about technological advancements in AD diagnosis and ethical considerations in AD research. In Neuromethods series style, chapters include the kind of detail and key advice from the specialists needed to get successful results in your laboratory.
Comprehensive and cutting-edge, Biomarkers for Preclinical Alzheimer's Disease is a valuable resource for individuals interested in the use of biomarker strategies to improve early AD detection. This book will be of great interest to researchers and clinicians from both academia and industry."
目次
Series Preface...
Preface...
Table of Contents...
Contributing Authors...
Part I Alzheimer's Disease as a Societal Challenge
1. Worldwide Economic Costs and Societal Burden of Dementia
Junfang Xu and Chengxuan Qiu
2. Epidemiology and Risk Factors of Alzheimer's Disease: A Focus on Diet
Cecilia Samieri
Part II Diagnostic Concepts
3. The Dimensional Structure of Subjective Cognitive Decline
Miguel A. Fernandez-Blazquez, Marina Avila-Villanueva, and Miguel Medina
4. Deriving and Testing the Validity of Cognitive-Reserve Candidates
Yaakov Stern and Christian Habeck
5. Methods for Pathological Classification of Alzheimer's Disease
Johannes Attems, Kirsty E. McAleese, and Lauren Walker
Part III Established Markers of Pathophysiology and Risk
6. Cerebrospinal Fluid Biomarkers of Preclinical Alzheimer's Disease
Panagiotis Alexopoulos and Chaido Sirinian
7. Brain Structural Imaging in Alzheimer's Disease
Sven Haller, Davide Zanchi, Cristelle Rodriguez, and Panteleimon Giannakopoulos
8. Brain Functional Imaging in Preclinical Alzheimer's Disease
Peter Haussermann, Thorsten Bartsch, and Oliver Granert
9. Imaging of Brain Amyloid Load in Early Alzheimer's Disease
Timo Grimmer and Jennifer Grace Perryman
10. Functional EEG Connectivity Alterations in Alzheimer's Disease
Florian Hatz and Peter Fuhr
Part IV Biomarker Discovery
11. A Selected Reaction Monitoring Protocol for the Measurement of sTREM2 in Cerebrospinal Fluid
Amanda J. Heslegrave, Wendy E. Heywood, Kevin M. Mills, Henrik Zetterberg
12. Soluble Amyloid Precursor Proteins in Blood: Methods and Challenges
Robert Perneczky and Panagiotis Alexopoulos
13. Tau Imaging in Preclinical Alzheimer's Disease
Paul Edison
14. Retinal Imaging in Early Alzheimer's Disease
Tom MacGillivray, Sarah McGrory, Tom Pearson, and James Cameron
15. In Vivo Volumetry of the Cholinergic Basal Forebrain
Michel J. Grothe, Ingo Kilimann, Lea Grinberg, Helmut Heinsen, and Stefan Teipel
Part V Patient Benefit and Ethical Considerations
16. Clinical Meaningfulness of Biomarkers Endpoints in Alzheimer's Disease Research
Kok Pin Ng, Tharick A. Pascoal, Xiaofeng Li, Pedro Rosa-Neto, and Serge Gauthier
17. The Ethics of Biomarker-Based Preclinical Diagnosis of Alzheimer's Disease
Alexander F. Kurz and Nicola T. Lautenschlager
18. Shared Decision-Making and Important Medical and Social Decisions in the Context of Early Diagnosis of Alzheimer's Disease
Katharina Bronner and Johannes Hamann
「Nielsen BookData」 より